Vitiligo Clinical Trial in Massachusetts

A phase-II, randomized, placebo-controlled trial
of simvastatin in generalized vitiligo

Principle Investigator:

John E. Harris, MD, PhD

Study Location: UMass Memorial Medical Center in Worcester, MA

A research trial at UMass is studying whether simvastatin, a common cholesterol medication, is useful in treating vitiligo. The study includes taking either this medication or a placebo and visiting UMass 8 times over a period of 6-7 months. You will be compensated for your time and receive free parking.

You may be eligible if you are a patient with vitiligo and are:

A male between 18 – 64 years of age

Not currently taking a statin medication for heart disease

If you are interested in participating or would like more detailed information: